Cite
HARVARD Citation
Oza, A. et al. (2017). Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study. International journal of gynecological cancer. 27 (1), pp. 50-58. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Oza, A. et al. (2017). Efficacy and Safety of Bevacizumab-Containing Therapy in Newly Diagnosed Ovarian Cancer: ROSiA Single-Arm Phase 3B Study. International journal of gynecological cancer. 27 (1), pp. 50-58. [Online].